Transarterial Chemoembolization Plus Sorafenib versus Transarterial Chemoembolization Alone for Advanced Hepatocellular Carcinoma: An Umbrella Review of Meta-Analyses and Systematic Reviews
Jingxin Yan,1,2,* Yonghao Wen,1,3,* Manjun Deng,1,2 Bin Ye,4 Xinlian Liu,5 Lushun Zhang5 1Department of Hepatopancreatobiliary Surgery, Affiliated Hospital of Qinghai University, Xining, People’s Republic of China; 2Qinghai Province Key Laboratory of Hydatid Disease Research, Xining, People’...
Furkejuvvon:
| Váldodahkkit: | , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Dove Medical Press
2023-10-01
|
| Ráidu: | Journal of Hepatocellular Carcinoma |
| Fáttát: | |
| Liŋkkat: | https://www.dovepress.com/transarterial-chemoembolization-plus-sorafenib-versus-transarterial-ch-peer-reviewed-fulltext-article-JHC |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
